These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24999778)

  • 1. Molecular imaging of the atherosclerotic plaque using positron emission tomography.
    Toor IS; Dweck MR; Newby DE
    J R Coll Physicians Edinb; 2014; 44(2):139-45. PubMed ID: 24999778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Imaging of Atheroma: Deciphering How and When to Use
    Tawakol A; Osborne MT; Fayad ZA
    Circ Cardiovasc Imaging; 2017 Mar; 10(3):. PubMed ID: 28292862
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose.
    Chen W; Dilsizian V
    Curr Cardiol Rep; 2013 Jun; 15(6):364. PubMed ID: 23605466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Will 18F-sodium fluoride PET-CT imaging be the magic bullet for identifying vulnerable coronary atherosclerotic plaques?
    Joshi NV; Vesey A; Newby DE; Dweck MR
    Curr Cardiol Rep; 2014 Sep; 16(9):521. PubMed ID: 25103772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study.
    Derlin T; Tóth Z; Papp L; Wisotzki C; Apostolova I; Habermann CR; Mester J; Klutmann S
    J Nucl Med; 2011 Jul; 52(7):1020-7. PubMed ID: 21680686
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Vesey AT; Jenkins WS; Irkle A; Moss A; Sng G; Forsythe RO; Clark T; Roberts G; Fletcher A; Lucatelli C; Rudd JH; Davenport AP; Mills NL; Al-Shahi Salman R; Dennis M; Whiteley WN; van Beek EJ; Dweck MR; Newby DE
    Circ Cardiovasc Imaging; 2017 Mar; 10(3):e004976. PubMed ID: 28292859
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Kitagawa T; Yamamoto H; Toshimitsu S; Sasaki K; Senoo A; Kubo Y; Tatsugami F; Awai K; Hirokawa Y; Kihara Y
    Atherosclerosis; 2017 Aug; 263():385-392. PubMed ID: 28528743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of
    Nogales P; Velasco C; Mota-Cobián A; González-Cintado L; Mota RA; España S; Mateo J; Bentzon JF
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):e480-e490. PubMed ID: 34289703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
    Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A
    J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Creager MD; Hohl T; Hutcheson JD; Moss AJ; Schlotter F; Blaser MC; Park MA; Lee LH; Singh SA; Alcaide-Corral CJ; Tavares AAS; Newby DE; Kijewski MF; Aikawa M; Di Carli M; Dweck MR; Aikawa E
    Circ Cardiovasc Imaging; 2019 Jan; 12(1):e007835. PubMed ID: 30642216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insight of functional molecular imaging into the atheroma biology: 18F-NaF and 18F-FDG in symptomatic and asymptomatic carotid plaques after recent CVA. Preliminary results.
    Quirce R; Martínez-Rodríguez I; Banzo I; Jiménez-Bonilla J; Martínez-Amador N; Ibáñez-Bravo S; López-Defilló J; Jiménez-Alonso M; Revilla MA; Carril JM
    Clin Physiol Funct Imaging; 2016 Nov; 36(6):499-503. PubMed ID: 26147617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary value of cardiac FDG PET and CT for the characterization of atherosclerotic disease.
    Stolzmann P; Subramanian S; Abdelbaky A; Maurovich-Horvat P; Scheffel H; Tawakol A; Hoffmann U
    Radiographics; 2011; 31(5):1255-69. PubMed ID: 21918043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Molecular Targets for Imaging of Atherosclerotic Plaque using Positron Emission Tomography.
    Werner RA; Bengel FM; Derlin T
    Curr Radiopharm; 2021; 14(3):173-183. PubMed ID: 32368992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of
    Kwiecinski J
    J Nucl Cardiol; 2024 May; 35():101845. PubMed ID: 38479575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of cardiovascular imaging in the journal of nuclear cardiology in 2015. Part 1 of 2: Plaque imaging, positron emission tomography, computed tomography, and magnetic resonance.
    AlJaroudi WA; Hage FG
    J Nucl Cardiol; 2016 Feb; 23(1):122-30. PubMed ID: 26542991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thoracic Aortic
    Fletcher AJ; Tew YY; Tzolos E; Joshi SS; Kaczynski J; Nash J; Debono S; Lembo M; Kwiecinski J; Bing R; Syed MBJ; Doris MK; van Beek EJR; Moss AJ; Jenkins WS; Walker NL; Joshi NV; Pawade TA; Adamson PD; Whiteley WN; Wardlaw JM; Slomka PJ; Williams MC; Newby DE; Dweck MR
    JACC Cardiovasc Imaging; 2022 Jul; 15(7):1274-1288. PubMed ID: 35183477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vulnerable plaque imaging using
    Kwiecinski J; Slomka PJ; Dweck MR; Newby DE; Berman DS
    Br J Radiol; 2020 Sep; 93(1113):20190797. PubMed ID: 31804143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In search of the vulnerable patient or the vulnerable plaque:
    Bellinge JW; Francis RJ; Majeed K; Watts GF; Schultz CJ
    J Nucl Cardiol; 2018 Oct; 25(5):1774-1783. PubMed ID: 29992525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Relevance of
    Lee JM; Bang JI; Koo BK; Hwang D; Park J; Zhang J; Yaliang T; Suh M; Paeng JC; Shiono Y; Kubo T; Akasaka T
    Circ Cardiovasc Imaging; 2017 Nov; 10(11):. PubMed ID: 29133478
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Kwiecinski J
    J Nucl Cardiol; 2022 Aug; 29(4):1710-1712. PubMed ID: 35277833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.